These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16427437)

  • 41. S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome.
    Oertel M; Schumacher U; McArthur DL; Kästner S; Böker DK
    J Clin Neurosci; 2006 Oct; 13(8):834-40. PubMed ID: 16931022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subarachnoid hemorrhage and cerebral vasospasm--facts and perspectives.
    Matula C
    Wien Klin Wochenschr; 2000 Jun; 112(12):519-22. PubMed ID: 10953869
    [No Abstract]   [Full Text] [Related]  

  • 43. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
    Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N
    Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subarachnoid clot volume correlates with age, neurological grade, and blood pressure.
    Rosen DS; Amidei C; Tolentino J; Reilly C; Macdonald RL
    Neurosurgery; 2007 Feb; 60(2):259-66; discussion 266-7. PubMed ID: 17290176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3. Elevation of serum magnesium may improve clinical outcome after aneursymal subarachnoid haemorrhage.
    Horner D
    Emerg Med J; 2011 Feb; 28(2):166-8. PubMed ID: 21239426
    [No Abstract]   [Full Text] [Related]  

  • 46. [Effect of magnesium sulphate and milrinone on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a randomized study].
    Soliman R; Zohry G
    Braz J Anesthesiol; 2019; 69(1):64-71. PubMed ID: 30409409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasodilation and neuroprotection: the magnesium saga in subarachnoid hemorrhage.
    Taccone FS
    Crit Care Med; 2010 May; 38(5):1382-4. PubMed ID: 20404634
    [No Abstract]   [Full Text] [Related]  

  • 48. Retrospective analysis of parenteral magnesium sulfate administration in decreased incidence of clinical and neuroradiological cerebral vasospasm: a single center experience.
    Friedlich D; Agner C; Boulos AS; Mesfin F; Feustel P; Bernardini GL; Popp AJ
    Neurol Res; 2009 Jul; 31(6):621-5. PubMed ID: 19660191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous Hydrogen Therapy With Intracisternal Magnesium Sulfate Infusion in Severe Aneurysmal Subarachnoid Hemorrhage.
    Takeuchi S; Kumagai K; Toyooka T; Otani N; Wada K; Mori K
    Stroke; 2021 Jan; 52(1):20-27. PubMed ID: 33349011
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous magnesium therapy in adult patients with an aneurysmal subarachnoid haemorrhage: a systematic review and meta-analysis.
    Yarad EA; Hammond NE
    Aust Crit Care; 2013 Aug; 26(3):105-17. PubMed ID: 23806874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of infusion therapy on central hemodynamics and the outcome of treatment in patients with subarachnoidal hemorrhages].
    Shatalov VI; Shchegolev AV
    Anesteziol Reanimatol; 2005; (4):55-8. PubMed ID: 16206589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of the therapeutic modalities when cerebral vasospasm occurs and the outcome of the treatment of patients with SAH].
    Milojević TM; Baljozović BV; Dostanić MM; Milaković BD; Djurović BM; Tasić GM; Jovanović VT; Nikolić IM
    Acta Chir Iugosl; 2008; 55(2):61-7. PubMed ID: 18792576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Magnesium sulphate for aneurysmal subarachnoid hemorrhage: why, how, and current controversy.
    Wong GK; Poon WS
    Acta Neurochir Suppl; 2013; 115():45-8. PubMed ID: 22890642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnesium activation of the calcium-sensing receptor, a mechanism to reduce infarction and vasospasm in subarachnoid hemorrhage.
    Smith SM
    Crit Care Med; 2010 Oct; 38(10):2083; author reply 2084-5. PubMed ID: 20856006
    [No Abstract]   [Full Text] [Related]  

  • 55. [Vasospasm treatment in intensive care].
    Bracco D; Chioléro R
    Rev Med Suisse Romande; 2000 Apr; 120(4):355-62. PubMed ID: 10859975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of magnesium sulfate therapy on patients with aneurysmal subarachnoid hemorrhage using serum S100B protein as a prognostic marker.
    Hassan T; Nassar M; Elhadi SM; Radi WK
    Neurosurg Rev; 2012 Jul; 35(3):421-7; discussion 427. PubMed ID: 22170177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Magnsium and vasospasm.
    Wong GK; Poon WS
    J Neurosurg; 2007 May; 106(5):938-9; author reply 939-40. PubMed ID: 17542548
    [No Abstract]   [Full Text] [Related]  

  • 58. Is There a Role of Intrathecal Calcium Channel Blockers in Treating Cerebral Vasospasm?
    Sadan O; Samuels OB
    World Neurosurg; 2021 Oct; 154():169-171. PubMed ID: 34583472
    [No Abstract]   [Full Text] [Related]  

  • 59. Magnesium sulfate administration in subarachnoid hemorrhage.
    Suarez JI;
    Neurocrit Care; 2011 Sep; 15(2):302-7. PubMed ID: 21748496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Effect of Fenestration of Lamina Terminalis on the Vasospasm and Shunt-Dependent Hydrocephalus in Patients Following Subarachnoid Haemorrhage.
    Hatefi M; Azhary S; Naebaghaee H; Mohamadi HR; Jaafarpour M
    J Clin Diagn Res; 2015 Jul; 9(7):PC15-8. PubMed ID: 26393164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.